Entrada Therapeutics Inc. is a biotechnology company focused on developing innovative therapies for devastating diseases. With a deep understanding of intracellular biology, the company’s platform enables the delivery of macromolecules directly into target cells, potentially revolutionizing the treatment landscape. Entrada’s cutting-edge approach holds significant promise for patients in urgent need of new treatment options.
